18F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism

被引:31
作者
Pretet, Valentin [1 ]
Rotania, Marianela [1 ,2 ]
Helali, Mehdi [1 ]
Ignat, Mihaela [3 ]
Vix, Michel [3 ]
Imperiale, Alessio [1 ,4 ,5 ]
机构
[1] ICANS Univ Hosp Strasbourg, Nucl Med & Mol Imaging, F-67033 Strasbourg, France
[2] Inst Oulton, Mol & Nucl Med, X5000 JJS, Cordoba, Argentina
[3] Univ Strasbourg, IRCAD IHU, Gen Digest & Endocrine Surg, F-67033 Strasbourg, France
[4] Univ Strasbourg, Fac Med, F-67033 Strasbourg, France
[5] CNRS Unistra, IPHC, Mol Imaging DRHIM, UMR 7178, F-67033 Strasbourg, France
关键词
F-18-Fluorocholine PET; 4D contrast-enhanced CT; primary hyperparathyroidism; parathyroid; adenoma; ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; COMPUTED-TOMOGRAPHY; LOCALIZATION; SCINTIGRAPHY; MANAGEMENT; SPECT/CT; SURGERY; UPDATE;
D O I
10.3390/jcm9062005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present retrospective study evaluates the diagnostic value of integrated(18)F-Fluorocholine positron emission tomography/four-dimensional contrast-enhanced computed tomography (F-18-FCH PET/4D-CT) as second-line imaging in preoperative work-up of primary hyperparathyroidism (pHPT), and compares(18)F-FCH PET with 4D-CT. Patients with pHPT and negative/discordant first-line imaging addressed for integrated(18)F-FCH PET/4D-CT were retrospectively selected. Sensitivity and detection rate (DR%) of(18)F-FCH PET/CT, 4D-CT, and PET/4D-CT were calculated according to the per patient and per lesion analyses, and afterwards compared. Histology associated with a decrease more than 50% of perioperative parathyroid hormone (PTH) blood level was used as a gold standard. Persistent high serum PTH and calcium levels during a 6-month follow-up was considered as presence of pHPT in both operated and non-operated patients. 50 patients (55 glands) were included. 44/50 patients (88%) were surgically treated. On a per patient analysis, sensitivity was 93%, 80%, and 95%, and DR% was 82%, 68%, and 84%, respectively for PET/CT, 4D-CT, and PET/4D-CT. PET/CT was more sensitive than 4D-CT (p= 0.046). PET/4D-CT performed better than 4D-CT (p= 0.013) but was equivalent to PET/CT alone. On a per gland analysis, sensitivity PET/CT, 4D-CT, and PET/4D-CT was 88%, 66%, and 92%, and DR% was 79%, 57%, and 83%, respectively. PET/CT and PET/4D-CT were more sensitive than 4D-CT alone (p= 0.01,p< 0.001, respectively). However, PET/CT and PET/4D-CT performed similarly. In conclusion,F-18-FCH PET provides better identification of hyperfunctioning parathyroids than 4D-CT and the combination of both did not significantly improve diagnostic sensitivity. Further investigations involving larger populations are necessary to define the role of(18)F-FCH PET/4D-CT as a "one-stop shop" second-line imaging in preoperative work-up of pHPT, especially considering the additional patient radiation exposure due to multi-phase CT.
引用
收藏
页数:12
相关论文
共 34 条
  • [21] Medical progress - Hyperparathyroid and hypoparathyroid disorders
    Marx, SJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) : 1863 - 1875
  • [22] Multiphase computed tomography for localization of parathyroid disease in patients with primary hyperparathyroidism: How many phases do we really need?
    Noureldine, Salem I.
    Aygun, Nafi
    Walden, Michael J.
    Hassoon, Ahmed
    Gujar, Sachin K.
    Tufano, Ralph P.
    [J]. SURGERY, 2014, 156 (06) : 1300 - 1307
  • [23] The diagnostic value of 4D MRI at 3T for the localization of parathyroid adenomas
    Ozturk, Mesut
    Polat, Ahmet Veysel
    Celenk, Cetin
    Elmali, Muzaffer
    Kir, Seher
    Polat, Cafer
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2019, 112 : 207 - 213
  • [24] Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile
    Piccardo, Arnoldo
    Trimboli, P.
    Rutigliani, M.
    Puntoni, M.
    Foppiani, L.
    Bacigalupo, L.
    Crescenzi, Anna
    Bottoni, G.
    Treglia, G.
    Paparo, F.
    Del Monte, P.
    Lanata, M.
    Paone, G.
    Ferrarazzo, G.
    Catrambone, U.
    Arlandini, A.
    Ceriani, L.
    Cabria, M.
    Giovanella, L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 766 - 775
  • [25] A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003
    Ruda, JM
    Hollenbeak, CS
    Stack, BC
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 132 (03) : 359 - 372
  • [26] Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis
    Sejean, K
    Calmus, S
    Durand-Zaleski, I
    Bonnichon, P
    Thomopoulos, P
    Cormier, C
    Legmann, P
    Richard, B
    Bertagna, XY
    Vidal-Trecan, GM
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (06) : 915 - 927
  • [27] Comparison of 4D CT, Ultrasonography, and 99mTc Sestamibi SPECT/CT in Localizing Single-Gland Primary Hyperparathyroidism
    Suh, Yong Joon
    Choi, June Young
    Kim, Su-jin
    Chun, In Kook
    Yun, Tae Jin
    Lee, Kyu Eun
    Kim, Ji-hoon
    Cheon, Gi Jeong
    Youn, Yeo-Kyu
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (03) : 438 - 443
  • [28] Taywade Sameer K, 2017, Indian J Endocrinol Metab, V21, P399, DOI 10.4103/ijem.IJEM_536_16
  • [29] Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis
    Treglia, Giorgio
    Piccardo, Arnoldo
    Imperiale, Alessio
    Strobel, Klaus
    Kaufmann, Philipp A.
    Prior, John O.
    Giovanella, Luca
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 751 - 765
  • [30] Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods
    Treglia, Giorgio
    Trimboli, Pierpaolo
    Huellner, Martin
    Giovanella, Luca
    [J]. MINERVA ENDOCRINOLOGICA, 2018, 43 (02) : 133 - 143